EXHIBIT 10.1
EXECUTION DOCUMENT
THIRD AMENDED AND RESTATED
REVOLVING CREDIT, TERM LOAN AND SECURITY AGREEMENT
THIS THIRD AMENDED AND RESTATED REVOLVING
CREDIT, TERM LOAN AND SECURITY AGREEMENT (the “Agreement” ) dated as
of April 11, 2007, is entered into among UNITED STATES
PHARMACEUTICAL GROUP, L.L.C. d/b/a NATIONSHEALTH , a Delaware
limited liability company (“ USPG ”),
NATIONSHEALTH HOLDINGS, L.L.C., a Florida limited liability
company (“ NHH ”), and NATIONSHEALTH, INC
., a Delaware corporation (“ NationsHealth ”)
(jointly and severally, the “Borrower” ) and
CAPITALSOURCE FINANCE LLC , a Delaware limited liability
company (the “Lender” ).
WHEREAS, pursuant to a certain Revolving Credit
and Security Agreement by and between USPG, NHH and Lender dated as
of April 30, 2004 (the “ Original Credit
Agreement ”), Lender made available to USPG and NHH a
revolving credit facility (the “Revolving
Facility” ) in a maximum principal amount at any time
outstanding of up to Ten Million Dollars ($10,000,000) (the
“Facility Cap” ); and
WHEREAS, USPG, NHH and Lender amended and
restated the Original Credit Agreement pursuant to a certain
Amended and Restated Revolving Credit and Security Agreement by and
among USPG, NHH and Lender dated as of June 29, 2004 (the
“ First Restated Credit Agreement ”) and a
certain Second Amended and Restated Revolving Credit and Security
Agreement by and among USPG, NHH and Lender dated March 21,
2006 (the “ Second Restated Credit Agreement ”);
and
WHEREAS, USPG and NHH have requested that Lender
further amend and restate the Second Restated Credit Agreement to
continue the Revolving Facility and to make available to Borrower a
multi-draw term loan (the “Term Loan” ) in a
maximum principal amount of Seven Million Dollars ($7,000,000) (the
“Term Loan Amount” ); and
WHEREAS, Lender is willing to amend and restate
the terms and conditions of the Second Restated Credit Agreement to
continue the Revolving Facility and make the Term Loan available to
Borrower upon the terms and subject to the conditions set forth
herein;
NOW,
THEREFORE, in consideration of the foregoing and for other good and
valuable consideration, the receipt and adequacy of which hereby
are acknowledged, Borrower and Lender hereby agree that the Second
Restated Credit Agreement shall be amended and restated as
follows:
1.1 General Terms
For
purposes of this Agreement, in addition to the definitions above
and elsewhere in this Agreement, the terms listed in
Appendix A and Annex I hereto shall have the
meanings given such terms in Appendix A and Annex
I , which are incorporated herein and made a part hereof. All
capitalized terms used which are not specifically defined herein
shall have meanings provided in Article 9 of the UCC in effect
on the date hereof to the extent the same are used or defined
therein. Unless otherwise specified herein or in
Appendix A , Annex I , any agreement, contract
or instrument referred to herein or in Appendix A or
Annex I shall mean such agreement, contract or instrument as
modified, amended, restated or supplemented from time to time.
Unless otherwise specified, as used in the Loan Documents or in any
certificate, report, instrument or other document made or delivered
pursuant to any of the Loan Documents, all accounting terms not
defined in Appendix A , Annex I or elsewhere in
this Agreement shall have the meanings given to such terms in and
shall be interpreted in accordance with GAAP.
|
|
|
|
|
|
|
|
|
II.
|
|
ADVANCES,
PAYMENT AND INTEREST
|
|
|
|
|
|
|
|
|
|
|
|
|
2.1
|
|
|
The
Revolving Facility
|
(a) Subject to the provisions of this
Agreement, Lender shall continue the Existing Advances and make
Advances to Borrower under the Revolving Facility from time to time
during the Term, provided that , notwithstanding any other
provision of this Agreement, the aggregate amount of all Advances
at any one time outstanding under the Revolving Facility shall not
exceed either of (a) the Facility Cap, or (b) the
Availability. The Revolving Facility is a revolving credit
facility, which may be drawn, repaid and redrawn, from time to time
as permitted under this Agreement. Any determination as to whether
there is Availability for Advances shall be made by Lender in its
sole discretion and, absent demonstrable error, is final and
binding upon Borrower. Unless otherwise permitted by Lender, each
Advance shall be in an amount of at least $1,000. Subject to the
provisions of this Agreement, Borrower may request Advances under
the Revolving Facility up to and including the value, in U.S.
Dollars, of the sum of (i) Eighty-Five percent (85%) of
the Borrowing Base for Eligible Billed Receivables, (ii) Sixty
percent (60%) of the Borrowing Base for Eligible Unbilled
Receivables, and (iii) as determined by Lender in its sole
discretion following the completion of the Inventory Field
Examination, either (a) Fifty percent (50%) of the Borrowing
Base for Eligible Finished Goods Inventory valued at the lower of
cost basis or market value or (b) Eighty-Five percent (85%) of
the Borrowing Base for Eligible Inventory valued at orderly
liquidation value, minus , the US Bio Reserve and, if
applicable, any other amounts adjusted or reserved pursuant to this
Agreement (such calculated amount being referred to herein as the
“Availability”); provided , however ,
that at no time shall more than Four Hundred Thousand Dollars
($400,000) of the Availability be comprised of Eligible Inventory.
Advances under the Revolving Facility automatically shall be made
for the payment of interest on the Advances and the Term Loan Draws
and other Obligations on the date when due to the extent available
and as provided for herein. The proceeds of Advances under the
Revolving Facility shall be used by Borrower (i) as a provider
of health care services, (ii) as a wholesaler, retailer and
provider of medical supplies and services, (iii) for the
generation of receivables/inventory, (iv) for the refinancing
of existing indebtedness, (v) for payments to Lender hereunder
and (vi) for any other lawful purpose permitted under this
Agreement.
(b) Lender has established the
above-referenced advance rate for Availability and, in its sole
credit judgment, may further adjust the Availability and such
advance rates by applying percentages (known as “liquidity
factors”) to Eligible Receivables by payor class based upon
Borrower’s actual recent collection history for each such
payor class (i.e., Medicare, Medicaid, commercial insurance, etc.)
and to Eligible Inventory in a manner consistent with
Lender’s underwriting practices and procedures, including
without limitation Lender’s review and analysis of, among
other things, Borrower’s historical returns, rebates,
discounts, credits and allowances (collectively, the
“Dilution Items” ). Such liquidity factors and
the advance rate for Availability may be adjusted by Lender
throughout the Term as warranted by Lender’s underwriting
practices and procedures in its sole credit judgment. Also, Lender
shall have the right to establish from time to time, in its sole
credit judgment, reserves against the Borrowing Base, which
reserves shall have the effect of reducing the amounts otherwise
eligible to be disbursed to Borrower under the Revolving Facility
pursuant to this Agreement.
2.2 Revolving Facility Maturity
Date
All
amounts outstanding under the Revolving Facility and other
Obligations relating to Advances shall be due and payable in full,
if not earlier in accordance with this Agreement, on the earlier of
(i) the occurrence and continuance of an Event of Default if
required pursuant hereto or Lender’s demand upon the
occurrence and continuance of an Event of Default, and
(ii) the last day of the Term (such earlier date being the
“Revolving Facility Maturity Date” ).
2.3 Revolving Facility Disbursements;
Requirement to Deliver Borrowing Certificate
So
long as no Default or Event of Default shall have occurred and be
continuing, Borrower may give Lender irrevocable written notice
requesting an Advance under the Revolving Facility by delivering to
Lender not later than 11:00 a.m. (Eastern Standard Time) at
least one (1) but not more than four (4) Business Days
before the proposed borrowing date of such requested Advance (the
“Borrowing Date” ), a completed Borrowing
Certificate and relevant supporting documentation satisfactory to
Lender, which shall (i) specify the proposed Borrowing Date of
such Advance which shall be a Business Day, (ii) specify the
principal amount of such requested Advance, (iii) certify the
matters contained in Section 4.2 , and
(iv) specify the amount of any Medicare or Medicaid
recoupments and/or recoupments of any third-party payor being
sought, requested or claimed, or, to Borrower’s knowledge,
threatened against Borrower or Borrower’s Affiliates. Each
time a request for an Advance is made, and, in any event and
regardless of whether an Advance is being requested, on Tuesday of
each week during the Term (and so long as a Default or Event of
Default exists, more frequently if Lender shall so request) until
the Obligations are indefeasibly paid in cash in full and this
Agreement is terminated, Borrower shall deliver to Lender a
Borrowing Certificate accompanied by a separate detailed aging and
categorizing of Borrower’s accounts receivable and accounts
payable and such other supporting documentation with respect to the
figures and information in the Borrowing Certificate as Lender
shall reasonably request from a credit or security perspective or
otherwise. On each Borrowing Date, Borrower irrevocably authorizes
Lender to disburse the proceeds of the requested Advance to the
appropriate Borrower’s account(s) as set forth on
Schedule 2.4 , in all cases for credit to the
appropriate Borrower (or to such other account as to which the
appropriate Borrower shall instruct Lender) via Federal funds wire
transfer no later than 4:00 p.m. (Eastern Standard Time).
Notwithstanding any provision of this Agreement to the contrary, if
the average outstanding balance under the Revolving Facility during
any calendar month is less than Two Million Five Hundred Thousand
Dollars ($2,500,000) Borrower acknowledges and agrees that Lender
shall be entitled to calculate interest and fees hereunder,
including without limitation, the calculations set forth in
Sections 2.4, 3.1 and 3.5 , as if the average
outstanding balance for such calendar month was Two Million Five
Hundred Thousand Dollars ($2,500,000). Notwithstanding the
requirement of Borrower delivering a Borrowing Certificate in
connection with each requested Advance, Borrower may give Lender
irrevocable written notice requesting an Advance under the
Revolving Facility in an amount necessary to make the total
outstanding Advances at such time equal Two Million Five Hundred
Thousand Dollars ($2,500,000), and so long as (i) no Default
or Event of Default shall have occurred and be continuing, and (ii)
Lender has a Borrowing Certificate that its not more than four
(4) Business Days before the proposed borrowing date of such
requested Advance, subject to Availability, Lender shall disburse
the proceeds of such requested Advance.
2.4 Revolving Facility Collections; Repayment;
Borrowing Availability and Lockbox
Each
Borrower shall maintain one or more lockbox accounts (individually
and collectively, the “Lockbox Account” ) with
one or more banks acceptable to Lender (each, a “Lockbox
Bank” ), and shall execute with each Lockbox Bank one or
more agreements acceptable to Lender (individually and
collectively, the “Lockbox Agreement” ), and
such other agreements related thereto as Lender may require. Each
Borrower shall ensure that all collections of their respective
Accounts and all other cash payments received by any Borrower,
including CIGNA Receipts, are paid and delivered directly from
Account Debtors and other Persons into the appropriate Lockbox
Account. The Lockbox Agreements shall provide that the Lockbox
Banks will transfer on the same Business Day all funds paid into
the Lockbox Accounts into a depository account or accounts
maintained by Lender or an Affiliate of Lender at such bank as
Lender may communicate to Borrower and the applicable Lockbox Bank
from time to time in accordance with the Lockbox Agreement (the
“Concentration Account” ), except, with respect
only to Accounts payable by Medicaid/Medicare Account Debtors, as
instructed by the applicable Borrower to whom such Accounts are
payable as permitted pursuant to the applicable Lockbox Agreement.
Notwithstanding and without limiting any other provision of any
Loan Document, Lender shall apply, on a daily basis, all funds
transferred into the Concentration Account pursuant to the Lockbox
Agreement and this Section 2.4 in such order and manner
as determined by Lender. To the extent that any Accounts are
collected by any Borrower or any other cash payments received by
any Borrower are not sent directly to the appropriate Lockbox
Account but are received by any Borrower or any of their
Affiliates, such collections and proceeds shall be held in trust
for the benefit of Lender and immediately remitted (and in any
event within two (2) Business Days), in the form received, to the
appropriate Lockbox Account for immediate transfer to the
Concentration Account. Borrower acknowledges and agrees that
compliance with the terms of this Section 2.4 is an
essential term of this Agreement, and that, in addition to and
notwithstanding any other rights Lender may have hereunder, under
any other Loan Document, under applicable law or at equity, upon
each and every failure by any Borrower or any of their Affiliates
to comply with any such terms Lender shall be entitled to assess a
non-compliance fee which shall operate to increase the Applicable
Rate by two percent (2.0%) per annum during any period of
non-compliance, whether or not a Default or an Event of Default
occurs or is declared, provided that nothing shall prevent Lender
from considering any failure to comply with the terms of this
Section 2.4 to be a Default or an Event of Default. All
funds transferred to the Concentration Account for application to
the Obligations under the Revolving Facility shall be applied to
reduce the Obligations under the Revolving Facility, but, for
purposes of calculating interest hereunder shall be subject to a
five (5) Business Day clearance period. If as the result of
collections of Accounts and/or any other cash payments received by
any Borrower pursuant to this Section 2.4 a credit
balance exists with respect to the Concentration Account, such
credit balance shall not accrue interest in favor of a Borrower,
but shall be available to Borrower upon Borrower’s written
request. If applicable, at any time prior to the execution of all
or any of the Lockbox Agreements and operation of all or any of the
Lockbox Accounts, each Borrower and their Affiliates shall direct
all collections or proceeds it receives on Accounts or from other
Collateral to the accounts(s) and in the manner specified by Lender
in its sole discretion.
2.5 The Term Loan Facility
Subject to the terms and conditions set forth in
this Agreement, Lender agrees to make the Term Loan available to
Borrower, so that as long as no Default or Event of Default has
occurred or is continuing, Borrower may, commencing as of the
Restatement Date from time to time prior to the close of business
on the Term Loan Draw Termination Date, borrow, in one or more Term
Loan Draws, an amount which does not to exceed in the aggregate the
Term Loan Amount; provided, however, that until the receipt and
approval by Lender of the Initial Appraisal, Lender shall only be
obligated to make (i) a Term Loan Draw in the amount of
$1,500,000 on the Restatement Date to fund the Minimum Liquidity
Amount and (ii) subsequent Term Loan Draws not to exceed the
amount of $2,000,000 in the aggregate (exclusive of the Term Loan
Draw referenced in clause (i) of this proviso) to fund
Diabetes Business Acquisitions permitted under this Agreement. So
long as no Default or Event of Default shall have occurred and be
continuing, Borrower may give Lender irrevocable written notice
requesting a Term Loan Draw by delivering to Lender not later than
11:00 a.m. (Eastern Standard Time) at least one (1) but
not more than four (4) Business Days before the proposed
borrowing date of such requested Term Loan Draw (the “Term
Loan Borrowing Date” ), a completed Borrowing Certificate
and relevant supporting documentation satisfactory to Lender, which
shall (i) specify the proposed Term Loan Borrowing Date which
shall be a Business Day, (ii) specify the principal amount of
such requested Term Loan Draw, (iii) certify the matters
contained in Section 4.2 and Section 4.3 . Subject
to contrary written instructions from Borrower, each Term Loan Draw
shall be disbursed on the applicable Term Loan Borrowing Date to
the appropriate Borrower’s account(s) as set forth on
Schedule 2.4 . The Term Loan is not a revolving credit
facility, and any repayments of principal shall be applied to
permanently reduce the Term Loan. The proceeds of the Term Loan
shall be used solely to fund the Minimum Liquidity Amount on the
Restatement Date and to finance the purchase price for, and the
reasonable fees, expenses and costs, incurred by Borrower in
connection with the acquisition of Diabetes Customer Lists as
permitted under this Agreement.
|
|
2.6
|
|
Repayment of
Term Loan; Maturity
|
Payment of the outstanding principal balance of
the Term Loan (in addition to the interest payments in
Section 3.2 ) and all other amounts (other than
interest) outstanding under the Term Loan shall be made as
follows:
(a) Commencing on January 1, 2008 (the
“ Initial Principal Repayment Date ”), and
continuing on the first day of each calendar month thereafter, the
outstanding principal amount of the Term Loan as of the Initial
Principal Repayment Date, together with accrued and unpaid interest
thereon, shall be payable in twenty nine (29) consecutive
monthly installments, the first twenty eight (28) of such
installments to be calculated on a straightline basis according to
an amortization schedule of twenty nine (29) months and, if
not sooner paid, the twenty ninth (29 th ) and final
installment of the then unpaid principal amount of the Term Loan,
together with accrued and unpaid interest thereon and all other
amounts due and owing under this Agreement with respect to the Term
Loan, shall be due and payable on the last day of the
Term.
(b) All Term Loan Obligations shall be due
and payable in full, if not earlier in accordance with this
Agreement, on the earlier of (i) the occurrence and
continuance of an Event of Default if required pursuant hereto or
Lender’s demand upon the occurrence and continuance of an
Event of Default, (ii) a Revolver Termination and
(iii) the last day of the Term, the earlier of the foregoing
(i), (ii) or (iii) being the “Term Loan Maturity
Date” .
2.7 Promise to Pay; Manner of
Payment
Borrower absolutely and unconditionally promises
to pay principal, interest and all other amounts payable hereunder,
or under any other Loan Document, without any right of rescission
and without any deduction whatsoever, including any deduction for
any setoff, counterclaim or recoupment, and notwithstanding any
damage to, defects in or destruction of the Collateral or any other
event, including obsolescence of any property or improvements. All
payments made by Borrower (other than payments automatically paid
through Advances under the Revolving Facility as provided herein),
shall be made only by wire transfer on the date when due, without
offset or counterclaim, in U.S. Dollars, in immediately available
funds to such account as may be indicated in writing by Lender to
Borrower from time to time. Any such payment received after 2:00
p.m. (Eastern Standard Time) on the date when due shall be deemed
received on the following Business Day. Whenever any payment
hereunder shall be stated to be due or shall become due and payable
on a day other than a Business Day, the due date thereof shall be
extended to, and such payment shall be made on, the next succeeding
Business Day, and such extension of time in such case shall be
included in the computation of payment of any interest (at the
interest rate then in effect during such extension) and/or fees, as
the case may be.
2.8 Repayment of Excess Advances
Any
balance of Advances under the Revolving Facility outstanding at any
time in excess of the lesser of the Facility Cap or the
Availability shall be immediately due and payable by Borrower
without the necessity of any demand, at the Payment Office, whether
or not a Default or Event of Default has occurred or is continuing
and shall be paid in the manner specified in Section 2.7
.
2.9 Payments by Lender
Should any amount required to be paid under any
Loan Document be unpaid, such amount may be paid by Lender, which
payment shall be deemed a request for an Advance under the
Revolving Facility as of the date such payment is due, and Borrower
irrevocably authorizes disbursement of any such funds to Lender by
way of direct payment of the relevant amount, interest or
Obligations. No payment or prepayment of any amount by Lender or
any other Person shall entitle any Person to be subrogated to the
rights of Lender under any Loan Document unless and until the
Obligations have been fully performed and paid irrevocably in cash
and this Agreement has been terminated. Any sums expended by Lender
as a result of any Borrower’s or any Guarantor’s
failure to pay, perform or comply with any Loan Document or any of
the Obligations may be charged to Borrower’s account as an
Advance under the Revolving Facility and added to the
Obligations.
2.10 Evidence of Loans
(a) Lender shall maintain, in accordance
with its usual practice, electronic or written records evidencing
the Indebtedness and Obligations to Lender resulting from each Loan
made by Lender from time to time, including without limitation, the
amounts of principal and interest payable and paid to Lender from
time to time under this Agreement. Lender and Borrower acknowledge
and agree that the Existing Advances under the Revolving Facility
have been evidenced by certain Revolving Notes dated April 30,
2004 in the aggregate principal amount of Ten Million Dollars
($10,000,000) (the “ Existing Revolving Notes
”). Lender and Borrower acknowledge and agree that (i) the
Existing Revolving Notes shall be cancelled by Lender and returned
to Borrower as of the Restatement Date but that the cancellation of
the Existing Revolving Notes shall not constitute a novation of the
Existing Advances or any other amounts evidenced thereby and
(ii) all Advances (including the Existing Advances) shall as
of the Restatement Date be evidenced as provided in this
Section 2.10(a) .
(b) The entries made in the electronic or
written records maintained pursuant to subsection (a) of this
Section 2.10 (the “ Register ”)
shall be prima facie evidence, absent manifest error, of the
existence and amounts of the Obligations and Indebtedness therein
recorded; provided however , that the failure of
Lender to maintain such records or any error therein shall not in
any manner affect the joint and several obligations of Credit
Parties to repay the Loans or Obligations in accordance with their
terms.
(c) Lender will account to Borrower monthly
with a statement of Advances under the Revolving Facility, and any
charges and payments made pursuant to this Agreement, and in the
absence of manifest error, such accounting rendered by Lender shall
be deemed final, binding and conclusive unless Lender is notified
by Borrower in writing to the contrary within fifteen calendar days
of Receipt of such accounting, which notice shall be deemed an
objection only to items specifically objected to
therein.
(d) Borrower agrees that:
(i) upon written notice by Lender to
Borrower that a Note or other evidence of Indebtedness is requested
by Lender to evidence the Loans and other Obligations owing or
payable to, or to be made by, Lender, Borrower shall promptly (and
in any event within three (3) Business Days of any such
request) execute and deliver to Lender an appropriate Note or Notes
in form and substance reasonably acceptable to Lender and
Borrower;
(ii) all references to Notes in the Loan
Documents shall mean Notes, if any, to the extent issued (and not
returned to Borrower for cancellation) hereunder, as the same may
be amended, modified, divided, supplemented, extended or restated
from time to time; and
(iii) upon Lender’s written request,
and in any event within three (3) Business Days of any such
request, Borrower shall execute and deliver to Lender new Notes and
divide the Notes in exchange for then existing Notes in such
smaller amounts or denominations as Lender shall specify in its
sole and absolute discretion; provided , that the aggregate
principal amount of such new Notes shall not exceed the aggregate
principal amount of the Notes outstanding at the time such request
is made; and provided, further, that such Notes that are to be
replaced shall then be deemed no longer outstanding hereunder and
replaced by such new Notes and returned to Borrower within a
reasonable period of time after Lender’s receipt of the
replacement Notes.
2.11 Grant of Security Interest;
Collateral
(a) To secure the payment and performance
of the Obligations, each Borrower hereby grants to Lender a
continuing security interest in and Lien upon, and pledges to
Lender, all of its right, title and interest in and to the
following (collectively and each individually, the “
Collateral ”), which security interest is intended to
be a first priority security interest:
(i) all of such Borrower’s tangible
personal property, including without limitation all present and
future Inventory and Equipment (including items of equipment which
are or become Fixtures), now owned or hereafter
acquired;
(ii) all of such Borrower’s
intangible personal property, including without limitation all
present and future Accounts, contract rights, Permits, General
Intangibles, Chattel Paper, Documents, Instruments, Deposit
Accounts, Investment Property, Letter-of-Credit Rights, Supporting
Obligations, rights to the payment of money or other forms of
consideration of any kind, tax refunds, insurance proceeds, now
owned or hereafter acquired, and all intangible and tangible
personal property relating to or arising out of any of the
foregoing;
(iii) all of such Borrower’s present
and future Government Contracts and rights thereunder and the
related Government Accounts and proceeds thereof, now or hereafter
owned or acquired by such Borrower; provided ,
however , that Lender shall not have a security interest in
any rights under any Government Contract of such Borrower or in the
related Government Account where the taking of such security
interest is a violation of an express prohibition contained in the
Government Contract (for purposes of this limitation, the fact that
a Government Contract is subject to, or otherwise refers to,
Title 31, § 203 or Title 41, § 15 of
the United States Code shall not be deemed an express prohibition
against assignment thereof) or is prohibited by applicable law,
unless in any case consent is otherwise validly obtained;
and
(iv) any and all additions and accessions
to any of the foregoing, and any and all replacements, products and
proceeds (including insurance proceeds) of any of the
foregoing.
(b) Notwithstanding the foregoing
provisions of this Section 2.11 , such grant of a
security interest shall not extend to, and the term
“Collateral” shall not include, any General Intangibles
of Borrower to the extent that (i) such General Intangibles
are not assignable or capable of being encumbered as a matter of
law or under the terms of any license or other agreement applicable
thereto (but solely to the extent that any such restriction shall
be enforceable under applicable law) without the consent of the
licensor thereof or other applicable party thereto, and
(ii) such consent has not been obtained; provided ,
however , that the foregoing grant of a security interest
shall extend to, and the term “Collateral” shall
include, each of the following: (a) any General Intangible
which is in the nature of an Account or a right to the payment of
money or a proceed of, or otherwise related to the enforcement or
collection of, any Account or right to the payment of money, or
goods which are the subject of any Account or right to the payment
of money, (b) any and all proceeds of any General Intangible
that is otherwise excluded to the extent that the assignment,
pledge or encumbrance of such proceeds is not so restricted, and
(c) upon obtaining the consent of any such licensor or other
applicable party with respect to any such otherwise excluded
General Intangible, such General Intangible as well as any and all
proceeds thereof that might theretofore have been excluded from
such grant of a security interest and from the term
“Collateral.”
(c) Upon the execution and delivery of this
Agreement, and upon the proper filing of the necessary financing
statements, recordation of the Collateral Patent, Trademark and
Copyright Assignment in the United States Patent and Trademark
Office and/or the United States Copyright Office without any
further action, Lender will have a good, valid and perfected first
priority Lien and security interest in the Collateral, subject to
no transfer or other restrictions or Liens of any kind in favor of
any other Person except for Permitted Liens. No financing statement
relating to any of the Collateral is on file in any public office
except those (i) on behalf of Lender, (ii) in connection with
Permitted Liens and/or (iii) those being
terminated.
2.12 Collateral Administration
(a) All Collateral (except Deposit
Accounts) will at all times be kept by Borrower at the locations
set forth on Schedule 5.18B hereto and shall not,
without thirty (30) calendar days prior written notice to
Lender, be moved therefrom unless Lender has entered into the
necessary documents to perfect and enforce its security interest
therein at such new location, and in any case shall not be moved
outside the continental United States.
(b) Borrower shall keep accurate and
complete records of its Accounts and all payments and collections
thereon and shall submit such records to Lender on such periodic
bases as Lender may request. In addition, if Accounts of Borrower
in an aggregate face amount in excess of $30,000 become ineligible
because they fall within one of the specified categories of
ineligibility set forth in the definition of Eligible Receivables,
Borrower shall notify Lender of such occurrence on the first
Business Day following such occurrence and the Borrowing Base shall
thereupon be adjusted to reflect such occurrence. Following the
occurrence and during the continuance of an Event of Default, if
requested by Lender, Borrower shall execute and deliver to Lender
formal written assignments (or, in the case of Medicaid/Medicare
Account Debtors, documents necessary to comply with the Federal
Assignment of Claims Act) of all of its Accounts weekly or daily as
Lender may request, including all Accounts created since the date
of the last assignment, together with copies of claims, invoices
and/or other information related thereto. To the extent that
collections from such assigned accounts exceed the amount of the
Obligations, such excess amount shall not accrue interest in favor
of Borrower, but shall be available to Borrower upon
Borrower’s written request.
(c) Following an occurrence or during the
continuance of an Event of Default, any of Lender’s officers,
employees, representatives or agents shall have the right, at any
time during normal business hours, in the name of Lender, any
designee of Lender or Borrower, to verify the validity, amount or
any other matter relating to any Accounts or Inventory of Borrower.
Borrower shall cooperate fully with Lender in an effort to
facilitate and promptly conclude such verification
process.
(d) To expedite collection, Borrower shall
endeavor in the first instance to make collection of its Accounts
for Lender. Lender shall have the right at all times after the
occurrence and during the continuance of an Event of Default to
notify (i) Account Debtors owing Accounts to Borrower other
than Medicaid/Medicare Account Debtors that their Accounts have
been assigned to Lender and to collect such Accounts directly in
its own name and to charge collection costs and expenses, including
reasonable attorney’s fees, to Borrower, and
(ii) Medicaid/Medicare Account Debtors that Borrower has
waived any and all defenses and counterclaims it may have or could
interpose in any such action or procedure brought by Lender to
obtain a court order recognizing the collateral assignment or
security interest and lien of Lender in and to any Account or other
Collateral and that Lender is seeking or may seek to obtain a court
order recognizing the collateral assignment or security interest
and lien of Lender in and to all Accounts and other Collateral
payable by Medicaid/Medicare Account Debtors.
(e) As and when determined by Lender in its
sole discretion but not more often than four (4) times per year
prior to the occurrence and continuance of an Event of Default,
Lender will perform the searches described in clauses (i) and
(ii) below against Borrower (the results of which are to be
consistent with Borrower’s representations and warranties
under this Agreement), all at Borrower’s expense:
(i) UCC searches with the Secretary of State of the
jurisdiction of organization of each Borrower and Guarantor and the
Secretary of State and local filing offices of each jurisdiction
where each Borrower and/or any Guarantors maintain their respective
executive offices, a place of business or assets; (ii) lien
searches with the United States Patent and Trademark Office and the
United States Copyright Office; and (iii) judgment, federal
tax lien and corporate and partnership tax lien searches, in each
jurisdiction searched under clause (i) above.
(f) Borrower (i) shall provide prompt
written notice to its current bank to transfer all items,
collections and remittances to the Concentration Account,
(ii) shall provide prompt written notice to each Account
Debtor (other than Medicaid/Medicare Account Debtors) that Lender
has been granted a lien and security interest in, upon and to all
Accounts applicable to such Account Debtor and shall direct each
Account Debtor to make payments to the appropriate Lockbox Account,
and Borrower hereby authorizes Lender, upon any failure to send
such notices and directions within ten (10) calendar days
after the date of this Agreement (or ten (10) calendar days
after the Person becomes an Account Debtor), to send any and all
similar notices and directions to such Account Debtors, and
(iii) shall do anything further that may be lawfully required
by Lender to create and perfect Lender’s lien on any
collateral and effectuate the intentions of the Loan Documents. At
Lender’s request, Borrower shall immediately deliver or make
arrangements to deliver to Lender all items for which Lender must
receive possession to obtain a perfected security interest and all
notes, certificates, and documents of title, Chattel Paper,
warehouse receipts, Instruments, and any other similar instruments
constituting Collateral.
2.13 Power of Attorney
Lender is hereby irrevocably made, constituted
and appointed the true and lawful attorney for Borrower (without
requiring Lender to act as such) with full power of substitution to
do the following: (i) endorse the name of any such Person upon
any and all checks, drafts, money orders, and other instruments for
the payment of money that are payable to such Person and constitute
collections on its or their Accounts; (ii) execute in the name
of such Person any financing statements, schedules, assignments,
instruments, documents, and statements that it is or they or are
obligated to give Lender under any of the Loan Documents; and
(iii) do such other and further acts and deeds in the name of
such Person that Lender may deem necessary or desirable to enforce
any Account or other Collateral or to perfect Lender’s
security interest or lien in any Collateral. In addition, if any
such Person breaches its obligation hereunder to direct payments of
Accounts or the proceeds of any other Collateral to the appropriate
Lockbox Account, Lender, as the irrevocably made, constituted and
appointed true and lawful attorney for such Person pursuant to this
paragraph, may, by the signature or other act of any of
Lender’s officers or authorized signatories (without
requiring any of them to do so), direct any federal, state or
private payor or fiscal intermediary to pay proceeds of Accounts or
any other Collateral to the appropriate Lockbox Account.
|
|
|
|
|
|
|
|
|
III.
|
|
INTEREST,
FEES AND OTHER CHARGES
|
|
|
|
|
|
|
|
|
|
|
|
|
3.1
|
|
|
Interest on
the Revolving Facility
|
Commencing May 1, 2007, and continuing
until the later of the expiration of the Term and the Payment in
Full and full performance of all of the Obligations and termination
of this Agreement interest on outstanding Advances under the
Revolving Facility shall be payable monthly in arrears on the first
day of each calendar month at an annual rate of Prime Rate plus
2.5% in accordance with the procedures provided for in
Section 2.7 and Section 2.4 ,
provided however , that, notwithstanding any
provision of any Loan Document, for the purpose of calculating
interest at any time hereunder, the Prime Rate shall be not less
than 4%, in each case calculated on the basis of a 360-day year and
for the actual number of calendar days elapsed in each interest
calculation period. The payment due under this
Section 3.1 on May 1, 2007 shall include any
accrued and unpaid interest on outstanding Advances under the
Revolving Facility existing under the Second Restated Credit
Agreement.
3.2 Interest on the Term Loan
Commencing May 1, 2007, and continuing
until the later of the expiration of the Term and the Payment in
Full and full performance of all of the Obligations and termination
of this Agreement interest on the outstanding principal balance of
the Term Loan shall be payable monthly in arrears on the first day
of each calendar month at an annual rate of Prime Rate plus 1.0% in
accordance with the procedures provided for in
Section 2.7 and Section 2.4. ,
provided however , that, notwithstanding any
provision of any Loan Document, for the purpose of calculating
interest at any time hereunder, the Prime Rate shall be not less
than 4%, in each case calculated on the basis of a 360-day year and
for the actual number of calendar days elapsed in each interest
calculation period. Advances under the Revolving Facility shall be
made automatically for the payment of Obligations under the Term
Loan on the date when due to the extent available and as provided
for herein.
3.3 Commitment Fees and Amended and Restated
Equity Participation Fee
(a) Borrower acknowledges that it is
obligated to pay (and does hereby agree to pay) the final
installment of One Hundred Thousand Dollars ($100,000) in respect
of non-refundable restatement fee which Borrower agreed to pay
under Section 3.1 of the Second Restated Credit Agreement on
March 21, 2008. Borrower acknowledges and agrees that such
installment shall be immediately due and payable upon the
termination of this Agreement (whether at maturity, by reason of
acceleration, by notice of intention to prepay, by required
prepayment or otherwise).
(b) In consideration of the making of the
Term Loan, Borrower hereby agrees to pay a non-refundable
commitment fee in the amount of One Hundred Five Thousand Dollars
($105,000) on the Restatement Date.
(c) In consideration of the making of the
Term Loan, Borrower hereby agrees to execute and deliver the Equity
Participation Fee Agreement as of the Restatement Date and
obligated itself to pay the fee set forth therein in accordance
with the terms and conditions of the Equity Participation Fee
Agreement.
3.4 Unused Line Fee
Borrower shall pay to Lender monthly an unused
line fee (the “Unused Line Fee” ) in an amount
equal to 0.04167% (per month) of the difference derived by
subtracting (i) the daily average amount of the balances under
the Revolving Facility outstanding during the preceding month, from
(ii) the Facility Cap. The Unused Line Fee shall be payable
monthly in arrears on the first day of each successive calendar
month commencing May 1, 2007 (which monthly payment shall
include any accrued and unpaid Unused Line Fee existing under the
Second Restated Credit Agreement).
3.5 Collateral Management Fee
Borrower shall pay Lender as additional interest
a monthly collateral management fee (the “Collateral
Management Fee” ) equal to 0.0833% per month calculated
on the basis of the daily average amount of the balances under the
Revolving Facility outstanding during the preceding month. The
Collateral Management Fee shall be payable monthly in arrears on
the first day of each successive calendar month commencing
May 1, 2007 (which monthly payment shall include any accrued
and unpaid Collateral Management Fee existing under the Second
Restated Credit Agreement).
3.6 Computation of Fees; Lawful
Limits
All
fees hereunder shall be computed on the basis of a year of
360 days and for the actual number of days elapsed in each
calculation period, as applicable. In no contingency or event
whatsoever, whether by reason of acceleration or otherwise, shall
the interest and other charges paid or agreed to be paid to Lender
for the use, forbearance or detention of money hereunder exceed the
maximum rate permissible under applicable law which a court of
competent jurisdiction shall, in a final determination, deem
applicable hereto. If, due to any circumstance whatsoever,
fulfillment of any provision hereof, at the time performance of
such provision shall be due, shall exceed any such limit, then, the
obligation to be so fulfilled shall be reduced to such lawful
limit, and, if Lender shall have received interest or any other
charges of any kind which might be deemed to be interest under
applicable law in excess of the maximum lawful rate, then such
excess shall be applied first to any unpaid fees and charges
hereunder, then to unpaid principal balance owed by Borrower
hereunder, and if the then remaining excess interest is greater
than the previously unpaid principal balance, Lender shall promptly
refund such excess amount to Borrower and the provisions hereof
shall be deemed amended to provide for such permissible rate. The
terms and provisions of this Section 3.6 shall control
to the extent any other provision of any Loan Document is
inconsistent herewith.
3.7 Default Rate of Interest
Upon
the occurrence and during the continuation of an Event of Default,
the Applicable Rate of interest in effect at such time with respect
to the Obligations shall be increased by 3.0% per annum (the
“Default Rate” ).
3.8 Acknowledgement of Joint and Several
Liability
Each
Borrower acknowledges that it is jointly and severally liable for
all of the Obligations under the Loan Documents. Each Borrower
expressly understands, agrees and acknowledges that (i) they are
all affiliated entities by common ownership, (ii) each
Borrower desires to have the availability of one common credit
facility instead of separate credit facilities, (iii) each
Borrower has requested that Lender extend such a common credit
facility on the terms herein provided, (iv) Lender will be
lending against, and relying on a lien upon, all of
Borrower’s assets even though the proceeds of any particular
loan made hereunder may not be advanced directly to a particular
Borrower, (v) each Borrower will nonetheless benefit by the
making of all such loans by Lender and the availability of a single
credit facility of a size greater than each could independently
warrant, and (vi) all of the representations, warranties,
covenants, obligations, conditions, agreements and other terms
contained in the Loan Documents shall be applicable to and shall be
binding upon each Borrower.
|
|
|
|
|
|
|
|
|
CONDITIONS
PRECEDENT
4.1
|
|
Conditions to Advances on or after Restatement
Date
|
The
obligations of Lender to consummate the transactions contemplated
herein and to make Advances and Term Loan Draws on or after the
Restatement Date are subject to the satisfaction, in the sole
judgment of Lender, of the following:
(a) (i) Borrower shall have delivered
to Lender this Agreement and, if required by Lender, amendments to,
or confirmations of, any of the other Loan Documents, each duly
executed by an authorized officer of Borrower and the other parties
thereto;
(b) all in form and substance satisfactory
to Lender in its sole discretion, Lender shall have received
(i) a report of Uniform Commercial Code financing statement,
tax and judgment lien searches performed with respect to Borrower
and Guarantor, if any, in each jurisdiction determined by Lender in
its sole discretion, and such report shall show no Liens on the
Collateral (other than Permitted Liens), (ii) each document
(including, without limitation, any Uniform Commercial Code
financing statement) required by any Loan Document or under law or
requested by Lender to be filed, registered or recorded to create
or continue in favor of Lender, a perfected first priority security
interest upon the Collateral, and (iii) evidence of each such
filing, registration or recordation and of the payment by Borrower
of any necessary fee, tax or expense relating thereto;
(c) Lender shall have received (i) the
Charter and Good Standing Documents, all in form and substance
acceptable to Lender, (ii) a certificate of the corporate
secretary or assistant secretary of each Borrower dated the
Restatement Date, as to the incumbency and signature of the Persons
executing this Agreement, in form and substance acceptable to
Lender, and (iii) the written legal opinion of counsel for
Borrower in form and substance satisfactory to Lender and its
counsel;
(d) Lender shall have received a
certificate of the chief financial officer (or, in the absence of a
chief financial officer, the chief executive officer) of each
Borrower, in form and substance satisfactory to Lender (each, a
“Solvency Certificate” ), certifying
(i) the solvency of such Person after giving effect to the
transactions and the Indebtedness contemplated by the Loan
Documents, and (ii) as to such Person’s financial
resources and ability to meet its obligations and liabilities as
they become due, to the effect that as of the Restatement Date and
after giving effect to such transactions and Indebtedness:
(A) the assets of such Person, at a Fair Valuation, exceed the
total liabilities (including contingent, subordinated, unmatured
and unliquidated liabilities) of such Person, and (B) no
unreasonably small capital base with which to engage in its
anticipated business exists with respect to such Person;
(e) Lender shall have completed
examinations, the results of which shall be satisfactory in form
and substance to Lender, of the Collateral, the financial
statements and the books, records, business, obligations, financial
condition and operational state of Borrower and Guarantor, and each
such Person shall have demonstrated to Lender’s satisfaction
that (i) its operations comply, in all respects deemed
material by Lender, in its sole judgment, with all applicable
federal, state, foreign and local laws, statutes and regulations,
(ii) its operations are not the subject of any governmental
investigation, evaluation or any remedial action which could result
in any expenditure or liability deemed material by Lender, in its
sole judgment, and (iii) it has no liability (whether
contingent or otherwise) that is deemed material by Lender, in its
sole judgment;
(f) all in form and substance satisfactory
to Lender in its sole discretion, Lender shall have received such
consents, approvals and agreements, including, without limitation,
any applicable Landlord Waivers and Consents with respect to any
and all leases set forth on Schedule 5.4 , from such
third parties as Lender and its counsel shall determine are
necessary or desirable with respect to (i) the Loan Documents
and/or the transactions contemplated thereby, and/or
(ii) claims against Borrower or Guarantor or the
Collateral;
(g) Borrower shall be in compliance with
Section 6.5 , and Lender shall have received copies of
all insurance policies or binders, original certificates of all
insurance policies of Borrower confirming that they are in effect
and that the premiums due and owing with respect thereto have been
paid in full and naming Lender as loss payee or additional insured,
as appropriate;
(h) Lender shall have received all fees,
charges and expenses payable to Lender on or prior to the
Restatement Date pursuant to the Loan Documents;
(i) all corporate and other proceedings,
documents, instruments and other legal matters in connection with
the transactions contemplated by the Loan Documents (including, but
not limited to, those relating to corporate and capital structures
of Borrower) shall be satisfactory to Lender;
(j) Borrower shall have executed and filed
an updated IRS Form 8821 with the appropriate office of the
Internal Revenue Service;
(k) Borrower shall have funded the Minimum
Liquidity Amount into the Minimum Liquidity Account; and
(l) Lender shall have received such other
documents, certificates, information or legal opinions as Lender
may reasonably request, all in form and substance reasonably
satisfactory to Lender.
4.2 Conditions to Each Advance
The
obligations of Lender to make any Advance are subject to the
satisfaction, in the Permitted Discretion of Lender, of the
following additional conditions precedent:
(a) Borrower shall have delivered to Lender
a Borrowing Certificate for the Advance executed by an authorized
officer of Borrower, which shall constitute a representation and
warranty by Borrower as of the Borrowing Date of such Advance that
the conditions contained in this Section 4.2 have been
satisfied; provided , however , that any
determination as to whether the conditions contained in this
Section 4.2 and the other conditions set forth in this
Agreement to Lender’s obligation to make Advances have been
satisfied shall be made by Lender in its Permitted
Discretion;
(b) each of the representations and
warranties made by Borrower in or pursuant to this Agreement shall
be accurate, before and after giving effect to such Advance, and no
Default or Event of Default shall have occurred or be continuing or
would exist after giving effect to the Advance under the Revolving
Facility on such date;
(c) immediately after giving effect to the
requested Advance, the aggregate outstanding principal amount of
Advances under the Revolving Facility shall not exceed either the
Availability or the Facility Cap;
(d) except as disclosed in the historical
financial statements, there shall be no liabilities or obligations
with respect to Borrower of any nature whatsoever which, either
individually or in the aggregate, would reasonably be likely to
have a Material Adverse Effect; and
(e) Lender shall have received all fees,
charges and expenses payable to Lender on or prior to such date
pursuant to the Loan Documents.
4.3
Conditions to Term Loan Draws
In
addition to the satisfaction of the conditions set forth in
Section 4.1 hereof, the obligation of the Lender to
make any Term Loan Draw for a Diabetes Business Acquisition is
subject to the satisfaction of the following conditions
precedent:
(a) Borrower shall have delivered to Lender
a Borrowing Certificate for the Term Loan Draw executed by an
authorized officer of Borrower, which shall constitute a
representation and warranty by Borrower as of the Term Loan
Borrowing Date of such Term Loan Draw that the conditions contained
in this Section 4.3 have been satisfied;
provided , however , provided , however
, that any determination as to whether the conditions contained in
this Section 4.3 and the other conditions set forth in
this Agreement to Lender’s obligation to make Term Loan Draw
have been satisfied shall be made by Lender in its Permitted
Discretion;
(b) each of the representations and
warranties made by Borrower in or pursuant to this Agreement shall
be accurate, before and after giving effect to such Term Loan Draw,
and no Default or Event of Default shall have occurred or be
continuing or would exist after giving effect to the Term Loan Draw
on such date;
(c) immediately after giving effect to the
requested Term Loan Draw, the aggregate outstanding principal
amount of all Term Loan Draws shall not exceed the Term Loan
Amount;
(d) except as disclosed in the historical
financial statements, there shall be no liabilities or obligations
with respect to Borrower of any nature whatsoever which, either
individually or in the aggregate, would reasonably be likely to
have a Material Adverse Effect;
(e) Lender shall have received all fees,
charges and expenses payable to Lender on or prior to such date
pursuant to the Loan Documents;
(f) All of the terms and conditions set
forth in Section 7.4 shall have been satisfied in form
and substance satisfactory to the Lender (or waived in writing by
the Lender); and
(g) Borrower shall promptly take such
actions, and execute and deliver such documents, agreements and
instruments as the Lender and its counsel shall require to insure
that the Lender obtain (subject to Permitted Liens) a first
priority perfected lien and security interest on any of the
properties and assets acquired by Borrower in connection with the
proposed Diabetes Business Acquisition, including but not being
limited to uniform commercial code financing statements and
termination statements, all of the foregoing to be acceptable to
the Lender and its counsel.
V.
REPRESENTATIONS AND WARRANTIES
Borrower, jointly and severally, represents and
warrants as of the date hereof and each Borrowing Date and Term
Loan Borrowing Date as follows:
5.1 Organization and Authority
Each
Borrower is a corporation or limited liability company duly
organized, validly existing and in good standing under the laws of
its state of formation. Borrower (i) has all requisite
corporate or limited liability company power and authority to own
its properties and assets and to carry on its business as now being
conducted and as contemplated in the Loan Documents, (ii) is
duly qualified to do business in every jurisdiction in which
failure so to qualify would reasonably be expected to have a
Material Adverse Effect, and (iii) has all requisite corporate
or limited liability company power and authority (A) to
execute, deliver and perform the Loan Documents to which it is a
party, (B) to borrow hereunder, (C) to consummate the
transactions contemplated under the Loan Documents, and (D) to
grant the Liens with regard to the Collateral pursuant to the
Security Documents to which it is a party. No Borrower is an
“investment company” registered or required to be
registered under the Investment Company Act of 1940, as amended, or
is controlled by such an “investment
company.”
5.2 Loan Documents
The
execution, delivery and performance by Borrower of the Loan
Documents to which it is a party, and the consummation of the
transactions contemplated thereby, (i) have been duly
authorized by all requisite action of each such Person and have
been duly executed and delivered by or on behalf of each such
Person; (ii) do not violate any provisions of
(A) applicable law, statute, rule, regulation, ordinance or
tariff, (B) any order of any Governmental Authority binding on
any such Person or any of their respective properties, or
(C) the certificate of incorporation or bylaws (or any other
equivalent governing agreement or document) of any such Person, or
any agreement between any such Person and its respective
stockholders, members, partners or equity owners or among any such
stockholders, members, partners or equity owners; (iii) are
not in conflict with, and do not result in a breach or default of
or constitute an event of default, or an event, fact, condition or
circumstance which, with notice or passage of time, or both, would
constitute or result in a conflict, breach, default or event of
default under, any indenture, agreement or other instrument to
which any such Person is a party, or by which the properties or
assets of such Person are bound; (iv) except as set forth
therein or Permitted Liens, will not result in the creation or
imposition of any Lien of any nature upon any of the properties or
assets of any such Person, and (v) except as set forth on
Schedule 5.2 , do not require the consent, approval or
authorization of, or filing, registration or qualification with,
any Governmental Authority or any other Person. When executed and
delivered, each of the Loan Documents to which Borrower is a party
will constitute the legal, valid and binding obligation of
Borrower, enforceable against Borrower in accordance with its
terms, subject to the effect of any applicable bankruptcy,
moratorium, insolvency, reorganization or other similar law
affecting the enforceability of creditors’ rights generally
and to the effect of general principles of equity which may limit
the availability of equitable remedies (whether in a proceeding at
law or in equity).
5.3 Subsidiaries, Capitalization and Ownership
Interests
Except as listed on Schedule 5.3 ,
Borrower has no Subsidiaries. NationsHealth Supply, L.L.C. is
presently inactive but has not been dissolved.
Schedule 5.3 states the authorized and issued
capitalization of Borrower, the number and class of equity
securities and/or ownership, voting or partnership interests issued
and outstanding of Borrower and the record and beneficial owners
thereof (including options, warrants and other rights to acquire
any of the foregoing) (provided however, beneficial ownership
information for NationsHealth is not required to be included in
Schedule 5.3). The ownership or partnership interests of each
Borrower that is a limited partnership or a limited liability
company are not certificated, the documents relating to such
interests do not expressly state that the interests are governed by
Article 8 of the Uniform Commercial Code, and the interests
are not held in a securities account. The outstanding equity
securities and/or ownership, voting or partnership interests of
Borrower have been duly authorized and validly issued and are fully
paid and nonassessable, and each Person listed on
Schedule 5.3 owns beneficially and of record all the
equity securities and/or ownership, voting or partnership interests
it is listed as owning free and clear of any Liens other than Liens
created by the Security Documents. Schedule 5.3 also
lists the directors, members, managers and/or partners of Borrower.
Except as listed on Schedule 5.3 , Borrower does not
own an interest in, participate in or engage in any joint venture,
partnership or similar arrangements with any Person.
5.4 Properties
Borrower (i) is the sole owner and has
good, valid and marketable title to, or a valid leasehold interest
in, all of its properties and assets, including the Collateral,
whether personal or real, subject to no transfer restrictions or
Liens of any kind except for Permitted Liens, and (ii) is in
compliance in all material respects with each lease to which it is
a party or otherwise bound. Schedule 5.4 lists all real
properties (and their locations) owned or leased by or to, and all
other assets or property that are leased or licensed by, Borrower
and all leases (including leases of leased real property) covering
or with respect to such properties and assets and all warehouses,
fulfillment houses or other locations at which any of
Borrower’s Inventory is located. Borrower enjoys peaceful and
undisturbed possession under all such leases and such leases are
all the leases necessary for the operation of such properties and
assets, are valid and subsisting and are in full force and effect.
All warehouse, fulfillment and other agreements relating to
Borrower’s Inventory are in full force and effect.
5.5 Other Agreements
Borrower is not (i) a party to any
judgment, order or decree or any agreement, document or instrument,
or subject to any restriction, which would affect its ability to
execute and deliver, or perform under, any Loan Document or to pay
the Obligations, (ii) in default in the performance,
observance or fulfillment of any obligation, covenant or condition
contained in any agreement, document or instrument to which it is a
party or to which any of its properties or assets are subject,
which default, if not remedied within any applicable grace or cure
period would reasonably be expected to have a Material Adverse
Effect, nor is there any event, fact, condition or circumstance
which, with notice or passage of time or both, would constitute or
result in a conflict, breach, default or event of default under,
any of the foregoing which, if not remedied within any applicable
grace or cure period would reasonably be expected to have a
Material Adverse Effect; or (iii) a party or subject to any
agreement, document or instrument with respect to, or obligation to
pay any, Management or Service Fee with respect to, the ownership,
operation, leasing or performance of any of its business or any
facility, nor is there any manager with respect to any such
facility.
5.6 Litigation
There
is no action, suit, proceeding or investigation pending or, to
their knowledge, threatened against Borrower that
(i) questions or could prevent the validity of any of the Loan
Documents or the right of Borrower to enter into any Loan Document
or to consummate the transactions contemplated thereby,
(ii) would reasonably be expected to be or have, either
individually or in the aggregate, any Material Adverse Change or
Material Adverse Effect, or (iii) would reasonably be expected
to result in any Change of Control or other change in the current
ownership, control or management of Borrower. Borrower is not aware
that there is any basis for the foregoing. Borrower is not a party
or subject to any order, writ, injunction, judgment or decree of
any Governmental Authority. There is no action, suit, proceeding or
investigation initiated by Borrower currently pending. Borrower has
no existing accrued and/or unpaid Indebtedness to any Governmental
Authority or any other governmental payor.
5.7 Hazardous Materials
Borrower is in compliance with all applicable
Environmental Laws. Borrower has not been notified of any action,
suit, proceeding or investigation (i) relating in any way to
compliance by or liability of Borrower under any Environmental
Laws, (ii) which otherwise deals with any Hazardous Substance
or any Environmental Law, or (iii) which seeks to suspend,
revoke or terminate any license, permit or approval necessary for
the generation, handling, storage, treatment or disposal of any
Hazardous Substance, except where such non-compliance would not
reasonably be expected to have a Material Adverse
Effect.
5.8 Potential Tax Liability; Tax Returns;
Governmental Reports
(a) Except as disclosed in
Schedule 5.8 , Borrower (i) has not received any
oral or written communication from the Internal Revenue Service
with respect to any investigation or assessment relating to the
Borrower directly, or relating to any consolidated tax return which
was filed on behalf of Borrower, (ii) is not aware of any year
which remains open pending tax examination or audit by the IRS, and
(iii) is not aware of any information that could give rise to
an IRS tax liability or assessment.
(b) Borrower (i) has filed all
federal, state, foreign (if applicable) and local tax returns and
other reports which are required by law to be filed by Borrower,
and (ii) has paid all taxes, assessments, fees and other
governmental charges, including, without limitation, payroll and
other employment related taxes, in each case that are due and
payable, except only for items that Borrower is currently
contesting in good faith with adequate reserves under GAAP, which
contested items are described on Schedule 5.8
.
5.9 Financial Statements and
Reports
All
financial statements and financial information relating to Borrower
that have been or may hereafter be delivered to Lender by Borrower
are accurate and complete in all material respects and have been
prepared in accordance with GAAP consistently applied with prior
periods. Borrower has no material obligations or liabilities of any
kind not disclosed in such financial information or statements, and
since the date of the most recent financial statements submitted to
Lender, there has not occurred any Material Adverse Change,
Material Adverse Effect or Liability Event or, to Borrower’s
knowledge, any other event or condition that would reasonably be
expected to have a Material Adverse Effect or cause or constitute a
Liability Event.
5.10 Compliance with Law
Borrower (i) is in compliance with all
laws, statutes, rules, regulations, ordinances and tariffs of any
Governmental Authority applicable to Borrower and/or
Borrower’s business, assets or operations, including, without
limitation, applicable requirements of the Standards for Privacy of
Individually Identifiable Health Information which were promulgated
pursuant to the Health Insurance Portability and Accountability Act
of 1996 (as amended, and collectively with the regulations
promulgated thereunder, “HIPAA” ), ERISA and
Healthcare Laws, and (ii) is not in violation of any order of
any Governmental Authority or other board or tribunal, except in
the case of (i) and (ii) above where noncompliance or
violation could not reasonably be expected to have a Material
Adverse Effect. There is no event, fact, condition or circumstance
which, with notice or passage of time, or both, would constitute or
result in any noncompliance with, or any violation of, any of the
foregoing, in each case except where noncompliance or violation
could not reasonably be expected to have a Material Adverse Effect.
Borrower has not received any notice that Borrower is not in
compliance in any respect with any of the requirements of any of
the foregoing. Borrower has (a) not engaged in any Prohibited
Transactions as defined in Section 406 of ERISA and
Section 4975 of the Internal Revenue Code of 1986, as amended,
and the rules and regulations promulgated thereunder, (b) not
failed to meet any applicable minimum funding requirements under
Section 302 of ERISA in respect of its plans and no funding
requirements have been postponed or delayed, (c) no knowledge
of any amounts due but unpaid to the Pension Benefit Guaranty
Corporation, or of any event or occurrence which would cause the
Pension Benefit Guaranty Corporation to institute proceedings under
Title IV of ERISA to terminate any of the employee benefit plans,
(d) no fiduciary responsibility under ERISA for investments
with respect to any plan existing for the benefit of Persons other
than its employees or former employees, or (e) not withdrawn,
completely or partially, from any multi-employer pension plans so
as to incur liability under the MultiEmployer Pension Plan
Amendments of 1980. With respect to Borrower, there exists no event
described in Section 4043 of ERISA, excluding
Subsections 4043(b)(2) and 4043(b)(3) thereof, for which the
thirty (30) day notice period contained in 12 C.F.R.
§ 2615.3 has not been waived. Borrower has maintained in
all material respects all records required to be maintained by the
Joint Commission on Accreditation of Healthcare Organizations, the
Food and Drug Administration, Drug Enforcement Agency and State
Boards of Pharmacy and the federal and state Medicare and Medicaid
programs as required by the Healthcare Laws and, to the best
knowledge of Borrower, there are no presently existing
circumstances which would reasonably be expected to result in
material violations of the Healthcare Laws. There is no Liability
Event.
5.11 Intellectual Property
Except as set forth on Schedule 5.11
, Borrower does not own, license or utilize, and is not a party to,
any material patents, patent applications, trademarks, trademark
applications, service marks, registered copyrights, copyright
applications, copyrights, trade names, trade secrets, software or
licenses (collectively, the “Intellectual
Property” ).
5.12 Licenses and Permits; Labor
Borrower is in compliance with and has all
Permits and Intellectual Property necessary or required by
applicable law or Governmental Authority for the operation of its
businesses except any of the foregoing which would not reasonably
be expected to have a Material Adverse Effect. All of the foregoing
are in full force and effect and not in known conflict with the
rights of others. Borrower is not (i) in breach of or default
under the provisions of any of the foregoing, nor is there any
event, fact, condition or circumstance which, with notice or
passage of time or both, would constitute or result in a conflict,
breach, default or event of default under, any of the foregoing
which, if not remedied within any applicable grace or cure period
would reasonably be expected to have a Material Adverse Effect,
(ii) a party to or subject to any agreement, instrument or
restriction that is so unusual or burdensome that it might have a
Material Adverse Effect, and/or (iii) and has not been,
involved in any labor dispute, strike, walkout or union
organization which would reasonably be expected to have a Material
Adverse Effect.
5.13 No Default
There
does not exist any Default or Event of Default or any event, fact,
condition or circumstance which, with the giving of notice or
passage of time or both, would constitute or result in a Default or
Event of Default.
5.14 Disclosure
No
Loan Document nor any other agreement, document, certificate, or
statement furnished to Lender by or on behalf of Borrower in
connection with the transactions contemplated by the Loan
Documents, nor any representation or warranty made by Borrower in
any Loan Document, contains any untrue statement of material fact
or omits to state any fact necessary to make the statements therein
not materially misleading. There is no fact known to Borrower which
has not been disclosed to Lender in writing which would reasonably
be expected to have a Material Adverse Effect.
5.15 Existing Indebtedness; Investments,
Guarantees and Certain Contracts
Except for Permitted Indebtedness, Borrower
(i) has no outstanding Indebtedness, (ii) is not subject
or party to any mortgage, note, indenture, indemnity or guarantee
of, with respect to or evidencing any Indebtedness of any other
Person, or (iii) does not own or hold any equity or long-term
debt investments in, and does not have any outstanding advances to
or any outstanding guarantees for the obligations of, or any
outstanding borrowings from, any Person. Borrower has performed all
material obligations required to be performed by Borrower pursuant
to or in connection with all Permitted Indebtedness and there has
occurred no breach, default or event of default under any document
evidencing any such items, including without limitation the MHR
Subordinated Debt, or any fact, circumstance, condition or event
which, with the giving of notice or passage of time or both, would
constitute or result in a breach, default or event of default
thereunder. Schedule 5.15 sets forth all Indebtedness
with a maturity date during the Term, and identifies such maturity
date.
5.16 Other Agreements
Except as set forth on Schedule 5.16
and Schedule 5.23 , (i) there are no existing or
proposed agreements, arrangements, understandings or transactions
between Borrower and any of Borrower’s officers, members,
managers, directors, stockholders, partners, other interest
holders, employees or Affiliates or any members of their respective
immediate families, and (ii) none of the foregoing Persons are
directly or indirectly, indebted to or have any direct or indirect
ownership, partnership or voting interest in, to Borrower’s
knowledge, any Affiliate of Borrower or any Person that competes
with Borrower (except that any such Persons may own stock in (but
not exceeding two (2%) percent of the outstanding capital stock of)
any publicly traded company that may compete with
Borrower.
5.17 Insurance
Borrower has in full force and effect such
insurance policies as are customary in its industry and as may be
required pursuant to Section 6.5 hereof. All such
insurance policies are listed and described on
Schedule 5.17 .
5.18 Names; Location of Offices, Records and
Collateral
During the preceding five years, Borrower has
not conducted business under or used any name (whether corporate,
partnership or assumed) other than as shown on
Schedule 5.18A . Borrower is the sole owner of all of
its names listed on Schedule 5.18A , and any and all
business done and invoices issued in such names are
Borrower’s sales, business and invoices. Each trade name of
Borrower represents a division or trading style of Borrower.
Borrower maintains its places of business and chief executive
offices only at the locations set forth on Schedule 5.18B ,
and all Accounts of Borrower arise, originate and are located, and
all of the Collateral, including Inventory, and all books and
records in connection therewith or in any way relating thereto or
evidencing the Collateral are located and shall only be located, in
and at such locations. All of the Collateral is located only in the
continental United States.
5.19 Non-Subordination
The
Obligations are not subordinated in any way to any other
obligations of Borrower or to the rights of any other
Person.
5.20 Accounts and Inventory
(a) In determining which Accounts are
Eligible Receivables, Lender may rely on all statements and
representations made by Borrower with respect to any Account.
Unless otherwise indicated in writing to Lender (including, without
limitation, any Borrowing Certificate), (i) each Account of
Borrower is genuine and in all respects what it purports to be and
is not evidenced by a judgment, (ii) each Account of Borrower
arises out of a completed, bona fide sale and delivery of goods or
rendering of Services by Borrower in the ordinary course of
business and in accordance with the terms and conditions of all
purchase orders, contracts, certifications, participations,
certificates of need and other documents relating thereto or
forming a part of the contract between Borrower and the Account
Debtor, (iii) each Account of Borrower is for a liquidated
amount maturing as stated in a claim or invoice covering such sale
of goods or rendering of Services, a copy of which has been
furnished or is available to Lender, (iv) each Account of
Borrower together with Lender’s security interest therein, is
not and will not be in the future (by voluntary act or omission by
Borrower), subject to any offset, lien, deduction, defense,
dispute, counterclaim or other adverse condition, is absolutely
owing to Borrower and is not contingent in any respect or for any
reason (except Accounts owed or owing by Medicaid/Medicare Account
Debtors that may be subject to offset or deduction under applicable
law), (v) there are no facts, events or occurrences which in
any way impair the validity or enforceability of any Account of
Borrower or tend to reduce the amount payable thereunder from the
face amount of the claim or invoice and statements delivered to
Lender with respect thereto, (vi) (A) to the knowledge of
Borrower, the Account Debtor under each Account of Borrower had the
capacity to contract at the time any contract or other document
giving rise thereto was executed and (B) to the knowledge of
Borrower, each such Account Debtor is solvent, (vii) to the
knowledge of Borrower, there are no proceedings or actions which
are threatened or pending against any Account Debtor under any
Account of Borrower which might result in any Material Adverse
Change in such Account Debtor’s financial condition or the
collectability thereof, (viii) each Account of Borrower has
been billed and forwarded to the Account Debtor for payment in
accordance with applicable laws and is in compliance and
conformance with any requisite procedures, requirements and
regulations governing payment by such Account Debtor with respect
to such Account, and, if due from a Medicaid/Medicare Account
Debtor, is properly payable directly to Borrower,
(ix) Borrower has obtained and currently has all material
Permits necessary in the generation of each Account of Borrower,
and (x) Borrower has disclosed to Lender on each Borrowing
Certificate the amount of all Accounts of Borrower for which
Medicare is the Account Debtor and for which payment has been
denied and subsequently appealed pursuant to the procedure
described in the definition of Eligible Receivables hereof.
Borrower is pursuing all available appeals in respect of such
Accounts which Borrower usually and customarily appeals in the
ordinary course of its business.
(b) In determining which Inventory is
Eligible Inventory, Lender may rely on all statements and
representations made by Borrower with respect to any Inventory.
Unless otherwise indicated in writing to Lender (including, without
limitation, any Borrowing Certificate), (i) Borrower has at
all times maintained correct and accurate records itemizing and
describing the kind, type, quality and quantity of Inventory in all
material respects, Borrower’s cost therefore and daily
withdrawals therefrom and additions thereto; (b) has not
removed any Inventory from the locations set forth or permitted
herein, except for sales of Inventory in the ordinary course of
Borrower’s business and except to move Inventory directly
from one location set forth or permitted herein to another such
location; (c) has produced, used, stored, shipped and
maintained Inventory with all reasonable care and caution and in
accordance with applicable standards of any insurance and in
conformity with applicable laws (including the requirements of the
Federal Fair Labor Standards Act of 1938, as amended and all rules,
regulations and orders related thereto); (d) except as set
forth on Schedule 5.20 , has not sold Inventory to any
customer on approval, or any other basis which entitles the
customer to return or may obligate Borrower to repurchase such
Inventory; (e) has kept Inventory in good and marketable
condition; and (f) has not acquired or accepted any Inventory
on consignment or approval except as set forth on
Schedule 5.20 and (g) has not permitted Inventory
to be subject to any Lien except Liens in favor of
Lender.
5.21 Healthcare
Without limiting or being limited by any other
provision of any Loan Document, Borrower has timely filed or caused
to be filed all cost and other reports of every kind required under
any Healthcare Laws or any provider or other agreement relating to
Borrower’s participation in Medicare or Medicaid programs.
Subject to subsection (a)(x) of Section 5.20 , there
are no claims, actions or appeals pending (and Borrower has not
filed any claims or reports which could reasonably result in any
such claims, actions or appeals) before any commission, board or
agency or other Governmental Authority, including, without
limitation, any intermediary or carrier, the Provider Reimbursement
Review Board or the Administrator of the Centers for Medicare and
Medicaid Services, with respect to any state or federal Medicare or
Medicaid cost reports or claims filed by Borrower, or any
disallowance by any commission, board or agency or other
Governmental Authority in connection with any audit of such cost
reports. No validation review or program integrity review related
to Borrower or the consummation of the transactions contemplated
herein or to the Collateral have been conducted by any commission,
board or agency or other Governmental Authority in connection with
the Medicare or Medicaid programs, and to the knowledge of
Borrower, no such reviews are scheduled, pending or threatened
against or affecting any of the providers, any of the Collateral or
the consummation of the transactions contemplated
hereby.
5.22 Survival
Borrower makes the representations and
warranties contained herein with the knowledge and intention that
Lender is relying and will rely thereon. All such representations
and warranties will survive the execution and delivery of this
Agreement and the making of the Advances under the Revolving
Facility and any Term Loan Draws.
|
|
5.23
|
|
MHR
Subordinated Debt and Employment Agreements
|
(a) Except as set forth on
Schedule 5.23 , no Borrower is in default in the
performance, observance or fulfillment of any obligation, covenant
or condition contained in the MHR Subordinated Note or any of the
documents, agreements and instruments executed and delivered in
connection therewith, nor is there any event, fact, condition or
circumstance which, with notice or passage of time or both, would
constitute or result in a conflict, breach, default or event of
default under any of the foregoing which, if not remedied within
any applicable grace or cure period could reasonably be expected to
have a Material Adverse Effect. There does not exist any default or
event of default or any event, fact, condition or circumstance,
which, with the giving of notice or passage of time or both, would
constitute or result in a default or event of default on the part
of any Borrower in connection with the MHR Subordinated Note. No
amendment or modification has been made to the MHR Subordinated
Note or any of the documents, agreements and instruments executed
and delivered in connection therewith.
(b) No Borrower is in default in the
performance, observance or fulfillment of any obligation, covenant
or condition contained in any Employment Agreement, nor is there
any event, fact, condition or circumstance which, with notice or
passage of time or both, would constitute or result in a conflict,
breach, default or event of default under any of the foregoing
which, if not remedied within any applicable grace or cure period
could reasonably be expected to have a Material Adverse Effect on
any Employment Agreement. No amendment or modification has been
made to any Employment Agreement which has not been provided to
Lender. No Employment Agreement has been terminated or, to
Borrower’s knowledge, threatened with termination.
|
VI.
|
|
AFFIRMATIVE
COVENANTS
|
Each
Borrower, jointly and severally, covenants and agrees that, until
full performance and satisfaction, and indefeasible payment in full
in cash, of all the Obligations and termination of this
Agreement:
|
|
6.1
|
|
Financial
Statements, Borrowing Certificate, Financial Reports and Other
Information
|
(a) Financial Reports . In addition
to providing the Borrowing Certificate in accordance with
Section 2.4 , Borrower shall furnish to Lender
(i) as soon as available and in any event within ninety
(90) calendar days after the end of each fiscal year of
Borrower (or such earlier date required by the laws, regulations
and rules of the Securities and Exchange Commission), audited
annual consolidated and consolidating financial statements of
Borrower, including the notes thereto, consisting of a consolidated
and consolidating balance sheet at the end of such completed fiscal
year and the related consolidated and consolidating statements of
income, retained earnings, cash flows and owners’ equity for
such completed fiscal year, which financial statements shall be
prepared and certified without qualification by an independent
certified public accounting firm satisfactory to Lender and
accompanied by related management letters, if available, and
(ii) as soon as available and in any event within thirty
(30) calendar days after the end of each calendar month,
unaudited consolidated and consolidating financial statements of
Borrower consisting of a balance sheet and statements of income,
retained earnings, cash flows and owners’ equity as of the
end of the immediately preceding calendar month. All such financial
statements shall be prepared in accordance with GAAP consistently
applied with prior periods. With each such financial statement,
Borrower shall also deliver a certificate of its chief financial
officer in substantially the form of Exhibit B hereto
(a “ Compliance Certificate ”) stating that
(A) such person has reviewed the relevant terms of the Loan
Documents and the condition of Borrower, (B) no Default or
Event of Default has occurred or is continuing, or, if any of the
foregoing has occurred or is continuing, specifying the nature and
status and period of existence thereof and the steps taken or
proposed to be taken with respect thereto, and (C) Borrower is
in compliance with all financial covenants attached as Annex I
hereto. Such certificate shall be accompanied by the calculations
necessary to show compliance with the financial covenants in a form
satisfactory to Lender and shall also set forth any payments made
in respect of Permitted Subordinated Debt as permitted under any
Subordination Agreement applicable thereto.
(b) Other Materials . Borrower
shall furnish to Lender as soon as available, and in any event
within ten (10) calendar days after the preparation or
issuance thereof or at such other time as set forth below:
(i) copies of such financial statements (other than those
required to be delivered pursuant to Section 6.1(a) )
prepared by, for or on behalf of Borrower and any other notes,
reports and other materials related thereto, including, without
limitation, any pro forma financial statements, (ii) any
reports, returns, information, notices and other materials that
Borrower shall send to its stockholders, members, partners or other
equity owners at any time, (iii) all Medicare and Medicaid
cost reports and other documents and materials filed by Borrower
and any other reports, materials or other information regarding or
otherwise relating to Medicaid or Medicare prepared by, for or on
behalf of Borrower, including, without limitation, (A) copies
of licenses and permits required by any applicable federal, state,
foreign or local law, statute ordinance or regulation or
Governmental Authority for the operation of its business,
(B) Medicare and Medicaid provider numbers and agreements,
(C) state surveys pertaining to any healthcare facility
operated, owned or leased by Borrower or any of its Affiliates or
Subsidiaries, and (D) participating agreements relating to medical
plans, (iv) (A) within fifteen (15) calendar days (thirty
(30) calendar days in the case of the first four
(4) months following the Restatement Date) (after the end of
each calendar month for such month, a summary report of the status
of all payments, denials and appeals of all Medicare and/or
Medicaid Accounts and accounts receivable and account payable aging
schedule and (B), within thirty (30) calendar days after the
end of each calendar month for such month, a sales and collection
report, including a report of sales, credits issued and collections
received, all such reports showing a reconciliation to the amounts
reported in the monthly financial statements, (v) promptly
upon receipt thereof, copies of any reports submitted to Borrower
by its independent accountants in connection with any interim audit
of the books of such Person or any of its Affiliates and copies of
each management control letter provided by such independent
accountants, (vi) within fifteen (15) calendar days after
the execution thereof, a copy of any contracts with the federal
government or with a Governmental Authority in the State of New
York, Vermont or Washington, and (vii) such additional
information, documents, statements, reports and other materials as
Lender may reasonably request from a credit or security perspective
or otherwise from time to time.
(c) Notices . Borrower shall
promptly, and in any event within three (3) calendar days
after Borrower or any authorized officer of Borrower obtains
knowledge thereof, notify Lender in writing of (i) any pending
or threatened litigation, suit, investigation, arbitration, dispute
resolution proceeding or administrative proceeding brought or
initiated by or against Borrower or otherwise affecting or
involving or relating to Borrower or any of their property or
assets to the extent (A) the amount in controversy exceeds
$30,000, or (B) to the extent any of the foregoing seeks
injunctive or declarative relief, (ii) any Default or Event of
Default, which notice shall specify the nature and status thereof,
the period of existence thereof and what action is proposed to be
taken with respect thereto, (iii) any other development,
event, fact, circumstance or condition that would reasonably be
likely to have a Material Adverse Effect, in each case describing
the nature and status thereof and the action proposed to be taken
with respect thereto, (iv) any notice received by Borrower
from any payor of a claim, suit or other action such payor has,
claims or has filed against Borrower in an amount exceeding
$30,000, (v) any matter(s) affecting the value, enforceability
or collectability of any of the Collateral, including, without
limitation, claims or disputes in the amount of $30,000 or more,
singly or in the aggregate, in existence at any one time,
(vi) any notice given by Borrower to any other lender of
Borrower, which notice to Lender shall be accompanied by a copy of
the applicable notice given to the other Lender, (vii) receipt
of any notice or request from any Governmental Authority or
governmental payor regarding any liability or claim of liability
(other than notices received from any Governmental Authority in
connection the usual and customary processing of claims by Borrower
in the ordinary course of business), (viii) any notice given
by or received by Borrower regarding any default, noncompliance,
proposed termination, waiver or consent under the MHR Subordinated
Note, the Employment Agreements, or the CIGNA Strategic Agreement,
and/or (ix) any Account becoming evidenced or secured by an
Instrument or Chattel Paper.
(d) Consents . Borrower shall
obtain and deliver from time to time all required consents,
approvals and agreements from such third parties as Lender shall
determine are necessary or desirable in its sole discretion, each
of which must be satisfactory to Lender in its sole discretion,
with respect to (i) the Loan Documents and the transactions
contemplated thereby, (ii) claims against Borrower or the
Collateral, and/or (iii) any agreements, consents, documents
or instruments to which Borrower is a party or by which any
properties or assets of Borrower or any of the Collateral is or are
bound or subject, including, without limitation, Landlord Waivers
and Consents with respect to leases and Warehouse Waivers and
Consents with respect to warehouse, fulfillment and similar
agreements.
(e) Operating Budget . Borrower
shall furnish to Lender on or prior to the Restatement Date and for
each fiscal year of Borrower thereafter not later than the earlier
of (i) thirty (30) calendar days after the end of each fiscal
year or (ii) thirty (30) calendar days after the same is
available, consolidated and consolidating month by month projected
operating budgets, annual projections, profit and loss statements,
balance sheets and cash flow reports of and for Borrower for such
upcoming fiscal year (including an income statement for each month
and a balance sheet as at the end of the last month in each fiscal
quarter), in each case prepared in accordance with GAAP
consistently applied with prior periods.
(f) Non-Compliance Fee . To the
extent any of the foregoing items in this Section 6.1 are
not delivered to Lender on a timely basis, Borrower shall be
obligated to Lender for a daily fee equal to the greater of (i)
$500, or (ii) five one-hundredths of one percent (0.05%) of
the then current outstanding principal balance of the Obligations,
for each day until such item is delivered to Lender, whether or not
a Default or Event of Default occurs or is declared, provided that
nothing shall prevent Lender from considering any failure to comply
with the terms of this Section 6.1 to be a Default or
an Event of Default.
6.2 Payment of Obligations
Borrower shall make full and timely indefeasible
payment in cash of the principal of and interest on the Loans,
Advances and all other Obligations.
6.3 Conduct of Business and Maintenance of
Existence and Assets
Borrower shall (i) conduct its business in
accordance with good business practices customary to the industry,
(ii) engage principally in the same or similar lines of
business substantially as heretofore conducted, (iii) collect
its Accounts in the ordinary course of business, (iv) maintain
all of its material properties, assets and equipment used or useful
in its business in good repair, working order and condition (normal
wear and tear excepted and except as may be disposed of in the
ordinary course of business and in accordance with the terms of the
Loan Documents and otherwise as determined by Borrower using
commercially reasonable business judgment), (v) from time to
time to make all necessary or desirable repairs, renewals and
replacements thereof, as determined by Borrower using commercially
reasonable business judgment, (vi) maintain and keep in full
force and effect its existence and all material Permits and
qualifications to do business and good standing in each
jurisdiction in which the ownership or lease of property or the
nature of its business makes such Permits or qualification
necessary and in which failure to maintain such Permits or
qualification could reasonably be expected to have a Material
Adverse Effect; and (vii) remain in good standing and maintain
operations in all jurisdictions in which currently located, except
where the failure to maintain such good standing could not
reasonably be expected to have a Material Adverse
Effect.
6.4 Compliance with Legal and Other
Obligations
Borrower shall (i) comply in all material
respects with all laws, statutes, rules, regulations, ordinances
and tariffs of all Governmental Authorities applicable to it or its
business, assets or operations, including applicable requirements
of the Standards for Privacy of Individually Identifiable Health
Information which were promulgated pursuant to HIPAA; (ii) pay
all taxes, assessments, fees, governmental charges, claims for
labor, supplies, rent and all other obligations or liabilities of
any kind, except liabilities being contested in good faith and
against which adequate reserves have been established in accordance
with GAAP, (iii) perform in accordance with its terms each
contract, agreement or other arrangement to which it is a party or
by which it or any of the Collateral is bound, except where the
failure to comply, pay or perform would not reasonably be expected
to have a Material Adverse Effect, (iv) maintain and comply
with all material Permits necessary to conduct its business and
comply with any new or additional requirements that may be imposed
on it or its business, and (v) properly file all
Medicaid/Medicare cost reports.
6.5 Insurance
Borrower shall (i) comply in all material
respects with all laws, statutes, rules, regulations, ordinances
and tariffs of all Governmental Authorities applicable to it or its
business, assets or operations, including applicable requirements
of the Standards for Privacy of Individually Identifiable Health
Information which were promulgated pursuant to HIPAA; (ii) pay
all taxes, assessments, fees, governmental charges, claims for
labor, supplies, rent and all other obligations or liabilities of
any kind, except liabilities being contested in good faith and
against which adequate reserves have been established in accordance
with GAAP, (iii) perform in accordance with its terms each
contract, agreement or other arrangement to which it is a party or
by which it or any of the Collateral is bound, except where the
failure to comply, pay or perform would not reasonably be expected
to have a Material Adverse Effect, (iv) maintain and comply
with all material Permits necessary to conduct its business and
comply with any new or additional requirements that may be imposed
on it or its business, and (v) properly file all
Medicaid/Medicare cost reports.
6.6 True Books
Borrower shall (i) keep true, complete and
accurate books of record and account in accordance with
commercially reasonable business practices in which true and
correct entries are made of all of its and their dealings and
transactions in all material respects; and (ii) set up and
maintain on its books such reserves as may be required by GAAP with
respect to doubtful accounts and all taxes, assessments, charges,
levies and claims and with respect to its business, and include
such reserves in its quarterly as well as year end financial
statements.
6.7 Inspection; Periodic Audits
Borrower shall permit the representatives of
Lender, at the expense of Borrower, from time to time during normal
business hours upon reasonable notice, to (i) visit and
inspect any of its offices or properties or any other place where
Collateral is located to inspect the Collateral and/or to examine
or audit all of its books of account, records, reports and other
papers (but not more often than four (4) times per year so
long as no Default or Event of Default exists), (ii) make copies
and extracts therefrom, and (iii) discuss its business,
operations, prospects, properties, assets, liabilities, condition
and/or Accounts and Inventory with its officers and independent
public accountants (and by this provision such officers and
accountants are authorized to discuss the foregoing).
6.8 Further Assurances; Post
Closing
At
Borrower’s cost and expense, Borrower shall (i) take
such further actions, obtain such consents and approvals and duly
execute and deliver such further agreements, assignments,
instructions or documents as Lender may request with respect to the
purposes, terms and conditions of the Loan Documents and the
consummation of the transactions contemplated thereby, and
(ii)&nbs